| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8225868 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 7 Pages |
Abstract
This study confirms the favorable prognosis for patients receiving gemcitabine therapy before CRT and the poor prognosis associated with increasing tumor volume. In addition, CRT in patients with abnormal hemoglobin and Stage III disease rarely induced tumor shrinkage allowing subsequent resection.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Jon K. M.D., Michael B. M.D., Ph.D., Helle A. M.D., Morten M.Sci., Ph.D., Per M.D., Ph.D.,